How to feed ourselves in a time of climate crisis
Here are 13 of the best ideas for a just and sustainable food system, from saving seeds to curbing food waste.
Ubiquitous threat: Microplastics discovered in every human placenta sample
This revelation underscores a growing environmental crisis, highlighting the pervasive infiltration of microplastics into the most intimate aspects of human life.
Judge to decide if Monsanto Roundup cancer lawsuits move forward at crucial hearing
During the week-long hearing – dubbed "Science Week" – epidemiologists, oncologists, toxicologists and other scientists representing both sides will offer testimony about glyphosate.
The globalized, industrialized food system is destroying the world—we urgently need to support local...
Our food system is linked to an economic system fundamentally biased against what’s good for people and the planet.
Medicare for all: A prescription for what ails us
There is no rational reason why Medicare couldn't be expanded to cover all Americans, regardless of age, from birth to death.
Pipeline resistance broadens: On the day Dakota Access oil flows, go one day without...
Let’s do what it takes to remind the companies, and the government itself, who’s really in charge of the economy.
An easier way to get to universal health care
Now is the time to push for better health care. Here are three modest, winnable first steps.
Navajo Nation has highest COVID-19 infection rate in the US
The Navajo Nation's alarming surge in cases is another example of an underserved and historically marginalized minority population being particularly vulnerable to the coronavirus pandemic.
STUDY: How TV news ignores the prescription drug price problem
A Media Matters review of weekday evening news coverage reveals the evening programs largely ignored the problem of escalating prescription drug prices.
Trump tax cuts helped health giants dodge billions while patients faced higher costs and...
New report finds seven major healthcare corporations avoided over $34 billion in taxes since 2017 while boosting buybacks, dividends, and executive pay as claim denials and patient safety issues escalated.